Bastian et al. found that platelet-activating factor acetylhydrolase expression in BRCA1 Mutant Ovarian cancer as a protective factor and potential negative regulator of the Wnt Signaling pathway. This evidence concerns the gene BRCA1 and ovarian carcinoma.